Al Razi Medical Co (SAU:9572) Beneish M-Score: -2.37 (As of Jul. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:9572 Al Razi Medical Co SAU:9572
45 GF Score
Price ﷼30.32
GF Value ﷼64.45
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Al Razi Medical Co Beneish M-Score?

Al Razi Medical Co SAU:9572 -2.88% 45 Beneish M-Score is -2.37 as of Jul. 21, 2026. GuruFocus rates SAU:9572 with a GF Score™ of 45/100 and a GF Value™ of ﷼64.45 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 628 Healthcare Providers & Services companies, Al Razi Medical Co ranks worse than 66.88% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.37 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Al Razi Medical Co's Beneish M-Score or its related term are showing as below:

SAU:9572' s Beneish M-Score Range Over the Past 10 Years
Min: -2.37   Med: -2.24   Max: -2.11
Current: -2.37

During the past 4 years, the highest Beneish M-Score of Al Razi Medical Co was -2.11. The lowest was -2.37. And the median was -2.24.

Al Razi Medical Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Al Razi Medical Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Al Razi Medical Co Beneish M-Score Chart

Al Razi Medical Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Beneish M-Score
0.00 0.00 -2.11 -2.37

Al Razi Medical Co Semi-Annual Data
Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial 0.00 0.00 -2.11 0.00 -2.37

Al Razi Medical Co Beneish M-Score Competitor Comparison

For the Pharmaceutical Retailers subindustry, Al Razi Medical Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Al Razi Medical Co Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Al Razi Medical Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Al Razi Medical Co's Beneish M-Score falls into.


SAU:9572
45GF Score
Al Razi Medical Co SAU:9572
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Al Razi Medical Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Al Razi Medical Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.6514+0.528 * 1.0422+0.404 * 0.4648+0.892 * 1.2124+0.115 * 1.3088
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9171+4.679 * -0.093809-0.327 * 1.2831
=-2.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was ﷼4.43 Mil.
Revenue was ﷼74.38 Mil.
Gross Profit was ﷼19.30 Mil.
Total Current Assets was ﷼29.34 Mil.
Total Assets was ﷼53.33 Mil.
Property, Plant and Equipment(Net PPE) was ﷼23.79 Mil.
Depreciation, Depletion and Amortization(DDA) was ﷼3.61 Mil.
Selling, General, & Admin. Expense(SGA) was ﷼3.35 Mil.
Total Current Liabilities was ﷼19.98 Mil.
Long-Term Debt & Capital Lease Obligation was ﷼8.64 Mil.
Net Income was ﷼0.82 Mil.
Gross Profit was ﷼0.00 Mil.
Cash Flow from Operations was ﷼5.82 Mil.
 Total Receivables was ﷼2.21 Mil.
Revenue was ﷼61.35 Mil.
Gross Profit was ﷼16.59 Mil.
Total Current Assets was ﷼22.15 Mil.
Total Assets was ﷼40.86 Mil.
Property, Plant and Equipment(Net PPE) was ﷼18.38 Mil.
Depreciation, Depletion and Amortization(DDA) was ﷼3.83 Mil.
Selling, General, & Admin. Expense(SGA) was ﷼3.01 Mil.
Total Current Liabilities was ﷼11.52 Mil.
Long-Term Debt & Capital Lease Obligation was ﷼5.58 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(4.431 / 74.384) / (2.213 / 61.351)
=0.059569 / 0.036071
=1.6514

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(16.589 / 61.351) / (19.298 / 74.384)
=0.270395 / 0.259438
=1.0422

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (29.338 + 23.789) / 53.332) / (1 - (22.149 + 18.377) / 40.864)
=0.003844 / 0.008271
=0.4648

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=74.384 / 61.351
=1.2124

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(3.827 / (3.827 + 18.377)) / (3.608 / (3.608 + 23.789))
=0.172356 / 0.131693
=1.3088

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(3.347 / 74.384) / (3.01 / 61.351)
=0.044996 / 0.049062
=0.9171

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((8.644 + 19.977) / 53.332) / ((5.576 + 11.515) / 40.864)
=0.536657 / 0.418241
=1.2831

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(0.819 - 0 - 5.822) / 53.332
=-0.093809

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Al Razi Medical Co has a M-score of -2.37 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.37 mean?
Al Razi Medical Co (SAU:9572) has a Beneish M-Score of -2.37 as of Jul. 21, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Al Razi Medical Co and its competitors. According to the industry distribution chart, Al Razi Medical Co ranks #420 out of 628 companies in the Healthcare Providers & Services industry, placing it in the top 66.9%.
Is Al Razi Medical Co's Beneish M-Score too high?
Al Razi Medical Co's current Beneish M-Score is -2.37. Based on the distribution chart, Al Razi Medical Co ranks #420 out of 628 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Al Razi Medical Co has a GF Score™ of 45/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Al Razi Medical Co's Beneish M-Score compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Al Razi Medical Co ranks #420 out of 628 companies for Beneish M-Score. This places Al Razi Medical Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Al Razi Medical Co and its competitors. Al Razi Medical Co's current Beneish M-Score is -2.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Al Razi Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Al Razi Medical Co (SAU:9572) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼64.45, compared to a current price of ﷼30.32 — trading 53% below its estimated fair value. The current Beneish M-Score is -2.37. Al Razi Medical Co's overall GF Score™ is 45/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Al Razi Medical Co (SAU:9572), the current Beneish M-Score is -2.37 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Al Razi Medical Co (SAU:9572) Overvalued in 2026?

Based on GuruFocus' analysis, Al Razi Medical Co stock appears to be undervalued. The current stock price of ﷼30.32 is trading 53% below its estimated GF Value™ of ﷼64.45. GuruFocus considers Al Razi Medical Co to be Significantly Undervalued.

Key valuation signals for SAU:9572:

  • Beneish M-Score: -2.37
  • GF Value™: ﷼64.45 vs. price of ﷼30.32 (53% below fair value)
  • GF Score™: 45/100 with 3 warning signs

No single metric tells the full story. See the SAU:9572 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Al Razi Medical Co Business Description

Address King Abdulaziz Road, Al-Khaleej District, Al-Bada'ea, Al-Qassim, Riyadh, SAU
Al Razi Medical Co operates in the medical field in the Kingdom of Saudi Arabia. The company provides all pharmaceutical and cosmetic products. It engages in buying and selling pharmaceuticals, medical supplies, herbal and cosmetic products, and all related products on a wholesale and retail basis.
45GF Score

Get the complete analysis for SAU:9572

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼30.32
Price
﷼64.45
GF Value